A Bim-targeting strategy overcomes adaptive bortezomib resistance in myeloma through a novel link between autophagy and apoptosis

Key Points Loss of Bim contributes to adaptive rather than intrinsic bortezomib resistance in multiple myeloma. A Bim-targeting strategy combining an HDACI with a BH3 mimetic overcomes such resistance through a new link between autophagy and apoptosis.